Cas:181696-35-5 Valdecoxib Sulfonic Acid manufacturer & supplier

We serve Chemical Name:Valdecoxib Sulfonic Acid CAS:181696-35-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Valdecoxib Sulfonic Acid

Chemical Name:Valdecoxib Sulfonic Acid
CAS.NO:181696-35-5
Synonyms:4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonic acid;4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonic acid;Benzenesulfonic acid, 4-(5-methyl-3-phenyl-4-isoxazolyl)-;4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonic acid;Parecoxib Impurity 25
Molecular Formula:C16H13NO4S
Molecular Weight:315.344
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.341±0.06 g/cm3
Index of Refraction:1.609
PSA:88.78000
Exact Mass:315.056519
LogP:1.60

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Parecoxib Impurity 25 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonic acid Use and application,4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonic acid technical grade,usp/ep/jp grade.


Related News: The FDA said its decision allows for the J&J doses to be used in the United States or exported. T Valdecoxib Sulfonic Acid manufacturer On April 8, a group of employees filed an anonymous complaint internally alleging that an executive at its Branchburg, New Jersey, factory had altered documents required by the U.S. Food and Drug Administration. Valdecoxib Sulfonic Acid supplier Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. Valdecoxib Sulfonic Acid vendor It also said it would bar South Koreans from visiting China as tourists. Valdecoxib Sulfonic Acid factory It also said it would bar South Koreans from visiting China as tourists.